Authors:
Sepideh Gholami, Yasmine Baca, Pavel Brodskiy, Joanne Xiu, Gulam Abbas Manji, Andreas Seeber, Anwaar Saeed, Benjamin Adam Weinberg, Moh’d M. Khushman, Rachna T. Shroff, Jim Abraham, Anthony Frank Shields, Heinz-Josef Lenz, John Marshall, Wolfgang Michael Korn, Emil Lou
Key Finding:
Colorectal cancer patients with high tumoral CXCR4 expression had improved survival when treated with pembrolizumab.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |